These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1318313
1. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system. Medcalf RL. J Biol Chem; 1992 Jun 15; 267(17):12220-6. PubMed ID: 1318313 [Abstract] [Full Text] [Related]
2. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate. Bergonzelli GE, Kruithof EK, Medcalf RL. Endocrinology; 1992 Sep 15; 131(3):1467-72. PubMed ID: 1354603 [Abstract] [Full Text] [Related]
3. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition. Nagamine Y, Ziegler A. EMBO J; 1991 Jan 15; 10(1):117-22. PubMed ID: 1846595 [Abstract] [Full Text] [Related]
4. Okadaic acid strongly increases gene transcription, mRNA and protein level for the urokinase receptor in human A549 cells. Lund LR, Danø K. FEBS Lett; 1992 Feb 24; 298(2-3):177-81. PubMed ID: 1312023 [Abstract] [Full Text] [Related]
5. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells. Peraldi MN, Rondeau E, Medcalf RL, Hagège J, Lacave R, Delarue F, Schleuning WD, Sraer JD. Biochim Biophys Acta; 1992 Apr 07; 1134(3):189-96. PubMed ID: 1558843 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines. Georg B, Helseth E, Lund LR, Skandsen T, Riccio A, Danø K, Unsgaard G, Andreasen PA. Mol Cell Endocrinol; 1989 Jan 07; 61(1):87-96. PubMed ID: 2501120 [Abstract] [Full Text] [Related]
7. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA. Dear AE, Costa M, Medcalf RL. FEBS Lett; 1997 Feb 03; 402(2-3):265-72. PubMed ID: 9037208 [Abstract] [Full Text] [Related]
8. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells. Georg B, Riccio A, Andreasen P. Mol Cell Endocrinol; 1990 Aug 20; 72(2):103-10. PubMed ID: 1704320 [Abstract] [Full Text] [Related]
9. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Schuster WA, Medcalf RL, Kruithof EK. Endocrinology; 1993 Oct 20; 133(4):1724-30. PubMed ID: 8404615 [Abstract] [Full Text] [Related]
10. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos. Kooistra T, Bosma PJ, Toet K, Cohen LH, Griffioen M, van den Berg E, le Clercq L, van Hinsbergh VW. Arterioscler Thromb; 1991 Oct 20; 11(4):1042-52. PubMed ID: 1648385 [Abstract] [Full Text] [Related]
11. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells. Antalis TM, Reeder JA. Int J Cancer; 1995 Sep 04; 62(5):619-26. PubMed ID: 7665235 [Abstract] [Full Text] [Related]
20. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH, Martin TJ. J Cell Physiol; 1995 Dec 15; 165(3):521-9. PubMed ID: 7593231 [Abstract] [Full Text] [Related] Page: [Next] [New Search]